SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-029488
Filing Date
2022-12-21
Accepted
2022-12-21 08:25:17
Documents
16
Period of Report
2022-12-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20221220_8k.htm   iXBRL 8-K 25874
2 EXHIBIT 99.1 ex_457729.htm EX-99.1 13613
7 a01.jpg GRAPHIC 7233
8 logo.jpg GRAPHIC 5546
  Complete submission text file 0001437749-22-029488.txt   204307

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20221221.xsd EX-101.SCH 3603
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20221221_def.xml EX-101.DEF 11534
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20221221_lab.xml EX-101.LAB 15416
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20221221_pre.xml EX-101.PRE 11690
10 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20221220_8k_htm.xml XML 2562
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 221476603
SIC: 2834 Pharmaceutical Preparations